Nutralliance, a California-based ingredient supplier specializing in foods, dietary supplements, beverages, and pet products, recently announced an exclusive sales and distribution agreement with Kääpä Biotech, a Finish company specializing in the wholesale of Nordic mushrooms, including Finnish-grown organic chaga, reishi, shiitake, cordyceps, lion’s mane, maitake, and turkey tail.
 
With sharp increases in demand for mushroom products, which are formulated for a number of applications in immune support and other wellness areas, both product manufacturers and consumers alike share heightened concern over where ingredients are sourced from, Eric Puro, Kääpä Biotech CEO, said.
 
“There is an increased demand for high-quality medicinal mushroom products in the North American market area,” he said. “The origin of the ingredients used in the food supplement industry is getting more important all the time. Our products are 100% of Finnish origin, from the FSC-certified Finnish sawdust substrate, to growing of mushrooms as well as processing and manufacturing of the mushroom extracts. We have full traceability and transparency in our process from spore to shipment. Therefore, we can guarantee premium quality mushroom extracts to the market.”
 
The company utilizes ultrasonic assisted extraction technology, which utilizes a combination of hot water and alcohol extraction, to isolate the desired bioactive compounds in each mushroom, Puro added. The company’s line of Nordic mushrooms include extracts in both powder and liquid format.
 
“The fungi kingdom and especially members of the Basidiomycota phylum (mushrooms) holds tremendous potential for natural, safe, and effective products that support a wide variety of health concerns as well as general well-being,” Brian Salerno, Nutralliance CEO, said. “To adequately fulfill modern North American consumers’ desires for superior quality in efficacy, safety, and traceability, as well as sustainability, we wanted to ensure our mycological expert source was able to put checkmarks in all those columns. Kääpä Biotech is that source.”